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ABSTRACT
We explored the existence of nucleoid DNA loops
in Escherichia coli by studying the distribution
of bacterial type II topoisomerases (Topo IIs).
Norfloxacin-induced high molecular weight (HMW)
DNA fragmentation of nucleoid, an event reminis-
cent of the excision of eukaryotic chromosomal
DNA loops mediated by topoisomerase II (TOP2).
The size of the HMW DNA fragments induced by
norfloxacin was affected by transcription, transla-
tion and growth phases of bacteria. The involvement
of bacterial Topo IIs in the generation of these HMW
DNA fragments is supported by the following
observations: (i) the excised loop-sized DNA frag-
ments were covalently linked to proteins; (ii) the
norfloxacin-induced excision of DNA loops was
highly reversible; (iii) coumermycin A1 antagonized
the excision of DNA loops induced by norfloxacin;
(iv) this antagonistic effect was reduced in either
gyrase or topo IV mutants conferring coumarin
resistance and (v) norfloxacin-induced reversible,
gyrase-mediated DNA cleavage in vitro. Importantly,
studies on coumarin- and/or quinolone-resistant
mutant strains showed that DNA gyrase, rather
than topoisomerase IV, plays the major role in the
generation of loop-sized HMW DNA fragments. In
sum, our study suggests a potential role of Topo IIs
in the arrangement of DNA supercoiling loop
domains in prokaryotic cells.
INTRODUCTION
Two levels of DNA organization in bacterial nucleoid and
eukaryotic chromatin have been suggested by earlier physical
and chemical studies, these being the supramolecular looped
organization and short-range structure (1–12). The looped
organization of bacterial nucleoid, which is suggested by
the existence of supercoiling-independent looped domains,
is presumably responsible for the long-range, higher-order
architecture of nucleoid DNA (8,13,14). The short-range
structure might be important in restraining DNA in a
negative-supercoiled state (12–14). In eukaryotic cells, chro-
mosome DNA is coated with at least an equal mass of pro-
teins, forming a complex termed chromatin (1,12,15).
Proteins, such as DNA topoisomerases, histones, histone-
like proteins and chromatin-associated proteins, have been
suggested to play important roles in both the regulation and
maintenance of chromatin structure (1,9–12,15–20). Import-
antly, these proteins not only play roles in structuring chro-
matin, but also in regulating DNA metabolism, such as
replication and transcription (1,9,21).
In the short-range nucleosome structure, DNA–histone
complexes are the fundamental units of eukaryotic chromatin
responsible for the ﬁrst order of DNA packing. Each nucle-
osome associates with one histone H1 molecule and the
bead-like structure coils into a 30 nm solenoid ﬁber. These
ﬁbers are then further folded into higher-order structures. A
radial loop model has been proposed for the supramolecular
organization of eukaryotic chromosome (15,20,22). In this
model, chromosome DNA is organized into large loops
(estimated as 50 to 100 kb in length) by periodic attachment
to the high-salt-insoluble, protein-based nuclear matrix/
scaffold (9,20,22–24). The matrix/scaffold-associated regions
(M/SARs) are repeated cis-acting DNA elements forming the
bases of looped domains (9,22–25). DNA TOP2 and other
matrix-associated proteins have been suggested to interact
with M/SAR sequences and form the protein complexes
for loop anchorage sites (11,22,25,26). Eukaryotic TOP2-
mediated excision of DNA loops has therefore been extens-
ively used to study the organization of chromosomal
long-range structure (11,17,27,28).
Several studies have revealed that many histone-like
components, such as H-NS, HU and IHF, participate in the
organization of short-range structure of bacterial nucleoid
(8,12). Although the presence of long-range, constrained
DNA supercoiling domains in prokaryotic nucleoid similar
to those in eukaryotic cells has been suggested from a number
of observations (3,6,13,29–31), our knowledge of the cis- and
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domains of bacterial nucleoid DNA and the factors that deﬁne
the boundaries of domains is limited (3,6,13). The domain
structure was apparent in early electron microscope (EM)
images of nucleoids in disrupted Escherichia coli (6,30,31)
and in later atomic force microscopy (AFM) images
(14,32). It is important to note that, although the nature of
the cellular components at the bases of the potential looped
arrangements is not known, each DNA loop has been
shown to be topologically independent (2,13). Subsequent
studies, including measuring the output of supercoil-sensitive
promoters, site-speciﬁc recombination between distinct
chromosomal sites, and sequence-speciﬁc DNA localization,
provided information on the dynamic and spatial aspects of
the nucleoid looped organization (33–37). The involvement
of bacterial topoisomerase IIs (Topo IIs) has also been sug-
gested from density gradient studies showing that the quino-
lone antibiotic, oxolinic acid, causes cleavage of nucleoid
DNA into large DNA fragments (38,39). However, the fac-
tors involved in the regulation of the long-range architecture
of bacterial nucleoid remain largely unexplored.
Two type II topoisomerases, DNA gyrase and topoi-
somerase IV (Topo IV), have been identiﬁed, and act in con-
cert with topoisomerase I (TopA), making an important
contribution to the steady-state levels of supercoiling in
E.coli (40). In addition, both Topo IIs have been found
to be targets for many quinolone antibiotics (40–42). In
mammalian cells, TOP2 excises chromosomal DNA loops
( 50 to 100 kb) in cells treated with TOP2-targeting drugs
(11,27,28). Here, we treated bacteria with a quinolone, nor-
ﬂoxacin, to induce DNA fragmentation of nucleoid DNA
and examined the relative contribution of gyrase and Topo
IV to norﬂoxacin-induced excision of high molecular weight
(HMW) nucleoid DNA fragments. First, we showed that bac-
terial nucleoid DNA was rapidly cleaved into loop-sized
DNA fragments ( 50 to 100 kb) by norﬂoxacin treatment,
indicating the potential existence of nucleoid DNA loops.
We then examined whether this effect was mediated by bac-
terial Topo IIs. This was demonstrated to be the case by the
tight association of proteins with HMW DNA fragments, the
reversible nature of DNA loop excision, and the ability of
coumermycin A1 to antagonize the fragmentation. We also
determined that DNA gyrase was more active in the genera-
tion of loop-sized HMW DNA fragments than DNA Topo IV.
In addition, studies using mutant strains suggested that E.coli
TopA and structural maintenance of chromosome (SMC)
proteins might also contribute to the overall organization of
nucleoid DNA loops. Taken together, our data suggest the
existence of Topo II-modulated supercoiling loop domains
in higher-order nucleoid DNA organization in prokaryotic
cells.
MATERIALS AND METHODS
Chemical, drugs and enzymes
Unless otherwise stated, all chemicals and drugs were
purchased from Sigma Chemical Co. Proteinase K (PK)
was obtained from Roche Applied Science Co. All drugs
were dissolved in dimethyl sulfoxide (DMSO) and were
stored in aliquots frozen at  20 C. Puriﬁed E.coli DNA
gyrase was kindly provided by Dr Martin Gellert (National
Institutes of Health, MD, USA).
Bacteria strains and growth conditions
Bacterial strains, LZ35–38 (43), 1358, 1359, 2819, 2822 and
2824, were obtained from Dr Nicholas R. Cozzarelli (UC
Berkeley, USA), strains DPB923, DPB924, CC4207 and
CC4208 (44) from Dr Stuart Austin (National Cancer
Institute, USA), and strains RFM443 and RFM445 from
Dr Yuk-Ching Tse-Dinh (New York Medical College, NY).
The genotypes of the E.coli strains used are described in
Table 1. All bacterial strains were maintained in Luria–
Bertani (LB) medium at 37 C with shaking (250 r.p.m.)
unless otherwise indicated.
Encapsulation of cells and drug treatment
After 30 min of norﬂoxacin treatment at 37 C (dosage as
indicated in the Figure legends), the cells were spun down
and resuspended to an optical density at 595 nm of 1 in
50 ml of LB medium. After mixing with an equal volume
of 1.0% (weight/volume) agarose premelted in LB, the sam-
ples were loaded into agarose plug makers (100 ml per plug).
After solidiﬁcation, the bacteria-containing agarose plug was
placed in 400 ml of lysis buffer [50 mM Tris (pH 8.0), 10 mM
EDTA and 0.5% SDS] with or without 0.5 mg/ml of PK and
incubated at 55 C for 24 h. The integrity of the nucleoid
DNA was then analyzed by pulsed-ﬁeld gel electrophoresis
(PFGE).
PFGE
PFGE was performed for 10 h at 14 C in 0.5· TBE [45 mM
Tris-base, 45 mM boric acid, 2 mM EDTA (pH 7.6)] in a
contour-clamped homogeneous electric ﬁeld apparatus
(CHEF, Bio-Rad) using conditions of 6 V/cm, an angle of
120 , and linear ramping with pulse times of 5–15 s and
15–60 s. After electrophoresis, the gel was stained with
ethidium bromide for 30 min at room temperature, then
photographed under ultraviolet (UV) light. For clarity, the
colors in the PFGE ﬁgures were inverted using the Photoshop
program. Fragment size was determined by comparison
with a l ladder PFG marker (New England Biolabs Inc.).
Table 1. Bacterial strains used
Strain Genotype Reference
LZ35 LZ36, except gyrA
L83 (43)
LZ36 W3101l, except zei-723:: Tn10, kan
R (43)
LZ37 LZ36, except gyrA
L83 parC
K84 (43)
LZ38 LZ36, except parC
K84 (43)
DPB923 DPB924 topA10 (44)
DPB924 Wild-type (44)
CC4207 DPB924 topA10 DmukB::kan (44)
CC4208 DPB924 DmukB::kan (44)
RFM443 rpsL galK2 Dlac74 (56)
RFM445 REFM443 gyrB221 (Cou
R) gyrB203(Ts) (56)
1358 F
- metB argE ilv tna (57)
1359 1358 gyrB234 (Cou
R, Ts) (57)
2822 1358 parE
R132C:cat (57)
2824 1359 parE
R132C:cat (57)
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Brieﬂy, BamHI-digested YEpG DNA was labeled at the
30 end using [a-
32P]dATP and the large fragment of E.coli
DNA polymerase I. The reaction mixture (20 ml ﬁnal volume)
contained 50 mM Tris (pH 8.0), 100 mM KCl, 8 mM MgCl2,
0.1 mM DTT, 0.5 mM EDTA, 30 mg/ml of BSA,  10 ng of
E.coli DNA gyrase and 10 ng of end-labeled [
32P] YEpG
DNA. Norﬂoxacin was added at the indicated concentration
to the reaction mixture, which was then incubated at 37 C
for 30 min, and the reaction terminated by addition of 5 ml
of stop buffer (5% SDS and 2.5 mg/ml of PK) and incubation
for 1 h at 37 C. The reaction products were separated on a
0.8% agarose gel in 0.5· TPE buffer [45 mM Tris-phosphate
(pH 8.0), 1 mM EDTA], then the gel was dried onto 3 MM
chromatographic paper and autoradiographed at  80 C
using Kodak XAR-5 ﬁlms.
RESULTS
Norfloxacin induces DNA fragmentation of nucleoid
Bacterial cells (LZ36) were treated with norﬂoxacin, encap-
sulated in agarose plugs, and the production of HMW DNA
fragments measured by PFGE. As shown in Figure 1
(the left panel), norﬂoxacin caused dose-dependent produc-
tion of HMW fragments. At concentrations of norﬂoxacin
>3 mM, nucleoid DNA was mainly cleaved into loop-sized
HMW DNA fragments ( 50–100 kb), similar in size to the
average DNA length of excised chromosomal DNA loops
induced by TOP2-tageting drugs in eukaryotic cells. This
conserved phenomenon (i.e. excision of nucleoid DNA
loops) strongly suggests that the bacterial chromosome is
organized into supramolecular looped domains like those in
eukaryotic cells. In addition, when norﬂoxacin was used at
concentrations >3 mM, a small fraction of the nucleoid
DNA was seen as more slowly migrating HMW DNA frag-
ments (200 to 600 kb and higher, indicated as ‘larger
HMW DNA fragments’ on Figure 1). Norﬂoxacin-induced
similar HMW DNA fragmentation in different kinds of
bacteria, including Staphylococcus aureus, Streptococcus
mutans, Klebsiella pneumoniae and Helicobacter pylori
(data not shown). Taken together, and consistent with a
previous report using oxolinic acid and sedimentation ana-
lysis (38,39), our results demonstrated that another quinolone,
norﬂoxacin, induced a similar cleavage pattern of bacterial
nucleoid.
The norfloxacin-induced HMW DNA fragments of
bacterial nucleoid are tightly linked to protein
We further characterized the HMW DNA fragments produced
by treatment of bacterial cells with 10 mM norﬂoxacin. When
drug-treated cells were lyzed in the absence of PK, the loop-
sized DNA fragments generated by norﬂoxacin treatment
disappeared completely and accumulation of larger HMW
DNA fragments in the region between the compression
zone and the wells was observed. It should be noted that
the amount of these protein-linked HMW DNA fragments
increased as the concentration of norﬂoxacin increased. Our
results also suggested that both the loop-sized and larger
HMW DNA fragments were tightly associated with proteins,
since the mobility of the HMW DNA fragments generated
by norﬂoxacin was signiﬁcantly less when PK was omitted
from the lysis buffer (Figure 1, right panel). This suggests
the involvement of a DNA topoisomerase in this nucleoid
DNA fragmentation process, since topoisomerase is known
to be covalently linked to broken ends of DNA in the
topoisomerase–DNA cleavable complex (39,45–48).
Modulation of norfloxacin-induced HMW DNA
fragmentation by transcription or translation inhibitors
Previous reports have shown that many cellular processes can
have different effects on the structure and membrane attach-
ment of nucleoid in E.coli, especially transcription (49–51).
In bacterial cells, translation is tightly coupled to transcrip-
tion (52). We therefore examined the effect of inhibitors of
transcription or translation on the norﬂoxacin-induced DNA
fragmentation. Treatment of LZ36 cells with either transla-
tion or transcription inhibitors did not result in HMW DNA
fragmentation (Figure 2A and B). Pretreatment of cells with
the translation inhibitors, chloramphenicol, tetracycline and
spectinomycin, had no effect on the norﬂoxacin-induced
HMW DNA fragmentation of nucleoid DNA (Figure 2A and
data not shown). However, pretreatment with 1 mM kanamy-
cin caused a change in the pattern of norﬂoxacin-induced
HMW DNA fragments (Figure 2A). Thus, depending
on their mechanisms of action, translation inhibitors had dif-
ferent effects on the DNA cleavage pattern of nucleoid
induced by norﬂoxacin treatment. As shown in Figure 2B,
the transcription inhibitor, rifampicin, also had an effect on
the HMW DNA fragmentation generated by norﬂoxacin,
Figure 1. Rapid fragmentation of nucleoid DNA into protein-linked HMW
DNA fragments in E.coli treated with norfloxacin. Bacterial cells were treated
with 0.1–100 mM norfloxacin for 30 min at 37 C, then were encapsulated in
agarose plugs and subjected to lysis with SDS in the presence or absence of
PK. Nucleoid integrity was then analyzed by PFGE as described in the
Materials and Methods. [PK: protease K; Norf: norfloxacin].
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from 50 kb to  75 kb in the presence of rifampicin. Taken
together, these results suggest that both transcription and a
kanamycin-sensitive translation process are involved in
norﬂoxacin-induced HMW DNA fragmentation, possibly
through modulation of the distribution of cleavage sites on
nucleoid DNA.
The norfloxacin-induced excision of nucleoid HMW
DNA fragments is reversible and can be antagonized
by coumermycin A1
The fact that the norﬂoxacin-induced nucleoid HMW DNA
fragments were linked to proteins immediately suggests the
involvement of a topoisomerase. The DNA fragmentation
induced by Topo II-targeting drugs/poisons is due to the
formation of reversible Topo II–DNA–drug cleavable com-
plexes (27,39,46,53), and heat-induced reversal (i.e. 55 C
treatment) is one of the unique properties of these com-
plexes (39,53). To conﬁrm the involvement of Topo II in
the excision of nucleoid DNA loops, we therefore tested
the antagonistic effect of a Topo II catalytic inhibitor and
for heat reversibility.
When the norﬂoxacin-treated cells were heated at 55 C for
various times prior to SDS lysis, the norﬂoxacin-induced
HMW DNA fragments disappeared in a time-dependent
manner, most being lost after 1.5 h at 55 C (Figure 3A,
lanes 5–7). It should be noted that, although less effective,
reversal by drug removal from the medium at 37 C also
caused reversal of norﬂoxacin-induced HMW DNA frag-
mentation (Figure 3A, compare lane 2 to lanes 3 and 4).
DNA gyrase is the target of the coumarin group of antibac-
terial agents (54,55), which are known to bind speciﬁcally to
the 24 kDa N-terminal subdomain of gyrase B, promote
dimerization and thereby inhibit the ATPase activity of
DNA gyrase (54). Interestingly, coumermycin A1 has been
shown to have an antagonistic effect on cell killing induced
by gyrase-targeting poisons, such as quinolone antibiotics
(45,55). We therefore tested its effect on the norﬂoxacin-
induced excision of nucleoid DNA loops. As shown in
Figure 3B, coumermycin A1 did not induce HMW DNA frag-
mentation (lane 3), but blocked norﬂoxacin-induced DNA
fragmentation in a dose-dependent manner (lanes 4–9).
Pretreatment of cells with coumermycin A1 at concentrations
>10 mM resulted in a marked reduction in norﬂoxacin-
induced loop-sized fragmentation of nucleoid DNA, i.e.
norﬂoxacin-induced nucleoid DNA fragmentation was effect-
ively antagonized by coumermycin A1. Thus, the excision
of nucleoid DNA loops following norﬂoxacin treatment was
most likely mediated through a DNA Topo II.
Figure 3. Norfloxacin-induced excision of DNA loops is mediated by DNA
topoisomerases. (A) Reversibility of norfloxacin-induced HMW nucleoid
DNA fragmentation. Cells were treated for 30 min at 37 C with 10 mM
norfloxacin, washed and encapsulated in agarose plugs. The plugs were then
subjected to different reversal conditions in drug-free LB media for various
times before analysis of fragmentation. (B) Coumermycin A1, a bacterial
TOP2 catalytic inhibitor, inhibits norfloxacin-induced HMW nucleoid DNA
fragmentation. Experiments were performed as described in Figure 2, except
that coumermycin A1 was used instead of translation or transcription
inhibitors. [CouA1: coumermycin A1].
Figure 2. Translation (A) and transcription (B) processes modulate HMW
DNA fragmentation in E.coli treated with norfloxacin. Bacterial cells were
pretreated for 30 min at 37 C with the indicated concentration of inhibitors of
translation (kanamycin or chloramphenicol) or transcription (rifampicin),
then for another 30 min with 10 mM norfloxacin in the continued presence of
the inhibitor. The cells were then encapsulated and PFGE performed to
examine the integrity of genomic DNA as described in the Materials and
Methods. [Kan: kanamycin; Cm: chloramphenicol; Rif: rifampicin].
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norfloxacin-induced HMW DNA fragmentation is
due to a specific inhibitory action on Topo II
DNA gyrase and Topo IV are targeted and inhibited by nor-
ﬂoxacin and coumermycin A1 (42,43,55). Mutant strains
carrying coumarin-resistant gyrase and/or topo IV mutations
(56,57) were used to conﬁrm that the molecular targets
of coumermycin A1 were DNA gyrase and Topo IV. For
example, coumermycin A1 cannot inhibit the catalytic activ-
ity of coumarin-resistant gyrase and therefore, coumermycin
A1 will not be able to antagonize mutant gyrase-mediated
DNA fragmentation induced by norﬂoxacin in coumarin-
resistant strains. As shown in Figure 4, the extent of
norﬂoxacin-induced HMW DNA fragmentation was less in
gyrase mutants (RFM445 and 1359) than in wild-type cells
(RFM443 and 1358), an observation consistent with the
temperature-sensitive phenotype of the gyrase mutations
of the strains (Table 1). Coumermycin A1 antagonized
norﬂoxacin-induced HMW DNA fragmentation in wild-type
RFM443 and 1358 cells, but not in coumarin-resistant
RFM445 cells [RFM443 gyrB221 (Cou
R)] and 1359
[gyrB234 (Cou
R)] cells. These results conﬁrmed that DNA
gyrase is an important in vivo target for both norﬂoxacin
and coumermycin A1. A similar antagonistic effect of
coumermycin on norﬂoxacin-induced HMW DNA frag-
mentation was seen using the topo IV mutant 2822 [1358
parE132 (Cou
R)] (Figure 4B, compare lanes 9 and 10), but
not using the double mutant 2824 [1358 gyrB234, parE132
(Cou
R)] (Figure 4B, compare lanes 12 and 13). These results
are consistent with the later observation (Figure 6B) that,
following norﬂoxacin treatment, Topo IV caused less
extensive cleavage of nucleoid DNA and at different sites,
compared to gyrase.
Norfloxacin induces gyrase-mediated reversible
DNA cleavage in vitro
We further tested the ability of norﬂoxacin to induce Topo II-
mediated DNA cleavage in vitro using puriﬁed recombinant
DNA gyrase as described previously (47,48). As shown in
Figure 5A, norﬂoxacin-induced dose-dependent formation
of DNA double-stranded breaks only in the presence of
DNA gyrase (lanes 2–5, 7–10). In addition, the norﬂoxacin-
induced, gyrase-mediated DNA cleavage was markedly
stimulated ( 100-fold) in the presence of 1 mM ATP
(compare lanes 5 and 8). We also examined whether the
norﬂoxacin-induced cleavage of DNA in the in vitro cleavage
assay was reversible and demonstrated, for the ﬁrst time, that
gyrase-mediated cleavage of DNA was highly reversible
Figure 4. Topo II is the target of coumermycin A1. (A) DNA gyrase is the
target for coumermycin A1. (B) DNA gyrase, but not Topo IV, is mainly
responsible for norfloxacin-induced HMW DNA fragmentation. Bacterial
cells were treated with 50 mM coumermycin A1 for 30 min, then 10 mM
norfloxacin was added and incubation continued for another 30 min at 30 C
before PFGE was carried out to examine nucleoid integrity. [Cou A1:
coumermycin A1; Norf: norfloxacin].
Figure 5. Norfloxacin induces reversible gyrase-mediated DNA double-
stranded breaks in vitro.( A) ATP stimulates gyrase-mediated DNA
cleavage in the presence of norfloxacin. Gyrase-mediated DNA cleavage in
the presence or absence of 1 mM ATP was examined as described in
the Materials and Methods using purified recombinant gyrase. (B) Gyrase-
mediated DNA cleavage induced by norfloxacin is reversible. Gyrase-
mediated DNA cleavage in the presence of 0.1 mM norfloxacin was examined
as described in the Materials and Methods. After incubation, duplicate
reaction mixtures were subjected for 15 min to different reversal conditions,
as indicated at the top of lanes 4 and 5, prior to addition of SDS plus PK.
3132 Nucleic Acids Research, 2006, Vol. 34, No. 10by either heat reversal (i.e. 55 C for 15 min, Figure 5B,
lane 4) or addition of 10 mM EDTA (Figure 5B, lane 5).
Taken together, these in vitro cleavage experiments provide
support for the idea that norﬂoxacin induces the formation
of reversible Topo II cleavable complexes.
Dissection of the distributions of gyrase and
Topo IV in nucleoid DNA
Two type II topoisomerases, gyrase and Topo IV, have been
identiﬁed in E.coli and have proposed to have different
cellular functions (43,58,59). Gyrase plays a major role in
the regulation of supercoiling and Topo IV is the main
decatenase for chromosome segregation (43,58,59). In this
section, we addressed the relative contributions of gyrase
and Topo IV to the norﬂoxacin-induced excision of HMW
DNA fragments, taking advantage of well-characterized
norﬂoxacin-resistant gyrase and/or Topo IV mutant strains
[LZ36 (wild-type), LZ35 (gyrA), LZ38 (parC) and LZ37
(gyrA, parC)] (43). As shown in Figure 6A, the resistance/
sensitivity of these bacterial cells to norﬂoxacin correlated
with their gyrase and/or Topo IV gene status as reported in
the literature (43).
Strain LZ35 confers resistance to norﬂoxacin due to a
mutation in gyrase, so the norﬂoxacin-induced cleavage of
HMW DNA fragments in LZ35 nucleoid is mainly through
DNA Topo IV proteins. On the other hand, LZ38 cells
have a mutation in the DNA Topo IV gene and thus, in
these cells, gyrase is the major enzyme causing the cleavage
of nucleoid into loop-sized HMW DNA fragments. PFGE
analysis revealed that the amount of loop-sized HMW DNA
fragments excised from nucleoid in the different strains
followed the hierarchy LZ36 > LZ38   LZ35 > LZ37
(Figure 6B), an observation consistent with the notion that
DNA gyrase play a more critical role than DNA Topo IV
in the formation of loop-sized HMW DNA fragments.
It should be noted that the HMW DNA fragmentation pat-
terns in the different mutants were quite distinct. Figure 6
shows that larger HMW DNA fragments (>200 kb, lane 6)
were the main product formed after norﬂoxacin-induced
HMW DNA fragmentation in LZ35 cells (Topo IV-mediated,
lane 6), while those formed in LZ38 cells (gyrase-mediated,
lane 9) were mainly loop-sized HMW DNA fragments
( 50 to 100 kb). This is in agreement with the notion that
gyrase play a more critical role in supramolecular DNA
loop organization. To summarize, our results showed that,
in addition to their biochemical activities, DNA gyrase and
topoisomerase IV differ in their locations on nucleoid
DNA. Given the fact that gyrase was more active in excision
of loop-sized DNA fragments from bacterial nucleoid than
Topo IV, it is plausible that gyrase plays a more important
role in the maintenance and/or organization of nucleoid
supercoiling loop domains (3,6,13,29–31). It should be
noted, in agreement with a report by Chen et al. (38), that
norﬂoxacin targeted both gyrase and Topo IV in vivo.
Roles of type I topoisomerases (TopA and TopB) and
SMC proteins in the Topo II-mediated excision of
HMW DNA fragments induced by norfloxacin
Topo IIs and DNA topoisomerase I (TopA) are the main
enzymes responsible for maintaining the overall supercoiling
state in E.coli (40). In addition, both topoisomerase II and
SMC proteins have been shown to play an important role in
the further condensation of looped structure in the eukaryotic
mitotic phase and to be crucial for the faithful segregation of
chromosomes in both prokaryotes and eukaryotes (1,60).
E.coli SMC proteins are encoded by the mukB/E/F genes
(1,44). Surprisingly, topA mutations were found to suppress
the growth and nucleoid organization deﬁciencies of muk
mutants (44). We therefore investigated the role of TopA
and SMC proteins in the Topo II-mediated excision of
HMW DNA fragments induced by norﬂoxacin.
Consistent with published results (44), only bacterial strain
CC4208, carrying a mukB mutation, was unable to form
colonies at 37 C (Figure 7A). In addition, a topA mutation
could partially compensate the temperature-sensitive pheno-
type of the mukB mutant (Figure 7A). Furthermore, the
Figure 6. Gyrase plays a more important role than Topo IV in bacterial DNA
looped domain organization. (A) Differential norfloxacin sensitivities of
gyrase and/or Topo IV mutant cells (LZ35 to LZ38). A series of 5-fold
dilutions of log-phase cells in LB medium was prepared and 5 ml of each
dilution dotted onto LB plates in the presence or absence of 1 mM
norfloxacin, then the plates were incubated at 37 C for 16 h and
photographed. (B) The same strains were grown to log-phase (OD595  
0.5), then treated with 10 mM of norfloxacin for 30 min at 37 C. The cells
were then encapsulated and their chromosome integrity analyzed by PFGE
as described in Figure 1.
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the topA mutant cells were more sensitive to norﬂoxacin
(Figure 7B).
Using PFGE, we found that norﬂoxacin-induced less
loop-sized fragmentation in the mukB strain, which contains
a loosed and disorganized nucleoid (44), than in wild-type
cells (Figure 7C), especially when the cells were pre-
incubated at a restrictive temperature for 2 h before
norﬂoxacin addition (compare lanes 15 and 13). No signiﬁc-
ant difference in loop excision was seen comparing the
wild-type and the topA mutant (Figure 7C, lanes 6 and 14).
However, topA mutation in the mukB mutant partially
restored norﬂoxacin-induced loop excision (compare
lanes 15 and 16). Our results therefore suggested that SMC
proteins, such as MukB, affect the global arrangement of
Topo IIs on nucleoid DNA.
E.coli contains four topoisomerases, TopA, gyrase,
Topo IV and TopB (topoisomerase III) (40). We therefore
examined the effect of topB deﬁciency on Topo II-mediated
cleavage of HMW DNA fragments induced by norﬂoxacin
treatment and found no signiﬁcant difference in loop excision
between the topB mutant (CRL3) (61) and the wild-type
(W3110) (data not shown). Thus, TopB, like TopA, does
not seem to contribute to the distribution of Topo II cleavage
sites induced by norﬂoxacin on nucleoid DNA.
Topo II-mediated excision of nucleoid loop-sized HMW
DNA fragments during different growth phases
AFM studies of bacterial nucleoid structure have shown that
nucleoid higher-order structure is signiﬁcantly affected by
the growth phase (32). We were therefore interested in
determining the patterns of Topo II-excised DNA loops dur-
ing different growth phases of LZ36 cells. As shown in
Figure 8, norﬂoxacin-induced loop excision was reduced
when the cell density reached 4.00 (OD595), an observation
consistent with a report that nuclear structure is more highly
compacted in stationary phase (32). However, we cannot rule
out the possibility that bacterial cells in stationary phase
might be more resistant to Topo II-targeting drugs as a result
of decreased drug uptake, increased drug efﬂux, or down-
regulation of Topo II.
Figure 7. Roles of topoisomerase I (TopA) and/or SMC-like protein (MukB) in nucleoid DNA looped domain organization. (A) Temperature sensitivity of the
wild-type and topA and/or mukB mutant strains. Log-phase cells [DPB924 (wild-type), DPB 923 (topA10), CC4208 (DmukB) or CC4207 (topA10, DmukB)] in LB
(23 C) were streaked onto LB plates, and then incubated at the indicated temperature for another 36 h. (B) Antibiotic sensitivity of the wild-type and topA and/or
mukB mutant strains. A series of 5-fold dilutions of cells grown to log-phase in LB (23 C) was prepared and 5 ml of each dilution dotted onto LB plates
containing the indicated antibiotics. Pictures were taken after 36 h incubation at 23 C. (C) Strains DPB924 (wild-type), DPB 923 (topA10), CC4208 (DmukB)o r
CC4207 (topA10, DmukB) were cultured at 23 C to log-phase (OD595   0.1), then divided into two groups. The first group was grown at the same temperature
until the OD595 reaches 0.5. The other group was incubated at a restrictive temperature (42 C) for 2 h to inactive MukB proteins in CC4208 cells. Both sets of
cells were then treated for 30 min with 10 mM norfloxacin at the same temperature, encapsulated in agarose plugs, and their nucleoid integrity analyzeda s
described in Figure 1.
3134 Nucleic Acids Research, 2006, Vol. 34, No. 10DISCUSSION
The length of DNA represents a great topological packaging
challenge for any given cell size. In eukaryotic cells, TOP2-
mediated excision of DNA loops ( 50 to 100 kb) using
TOP2-targeting drugs has been extensively used to study
the organization of chromosomal long-range structure
(11,17,27,28). Here, we found that, in bacteria, norﬂoxacin-
induced Topo II-mediated excision of chromosomal DNA
into HMW DNA loop fragments with a non-random, limited
loop-size ( 50 to 100 kb). We also demonstrated that DNA
gyrase, rather than DNA Topo IV, was the main Topo II
responsible for the norﬂoxacin-induced excision of nucleoid
DNA into loop-sized HMW DNA fragments. However, con-
sistent with a previous report using sedimentation analysis
(38), Topo IV was located at most widely spread sites
on nucleoid than gyrase. Our demonstration that bacterial
Topo IIs cleaved nucleoid into loop-sized HMW DNA frag-
ments suggests that chromatin structure at the level of the
higher-order DNA loop structure is probably conserved in
nucleoid DNA in prokaryotes. This notion is supported by
early demonstrations of independent supercoiling domains
(3,6,13,29–31) and the Topo II-mediated cleavage of nucle-
oid using oxolinic acid and ciproﬂoxacin (38,39).
Norﬂoxacin, oxolinic acid and ciproﬂoxacin are all quino-
lone antibiotics. However, the average size of norﬂoxacin-
induced HMW DNA fragments reported in our study
( 50 kb), while similar to that of the fragments induced by
ciproﬂoxacin (38), was smaller than for those induced
by oxolinic acid ( 100 kb) (39). This difference can be
explained by the fact that both norﬂoxacin and ciproﬂoxacin
target gyrase and DNA topoisomerase IV, while oxolinic acid
mainly targets gyrase (38,43). It is therefore reasonable to
speculate that the smaller DNA fragments generated by
norﬂoxacin or ciproﬂoxacin are due to additional Topo IV-
mediated DNA cleavage of nucleoid DNA. The different
distributions of gyrase and Topo IV on nucleoid might well
correlate with their different cellular functions. As mentioned
above, TOP2-mediated excision of chromosomal DNA loops
has been used in mammalian system to probe the structure
of the higher-order loop organization of the chromosome.
In addition, TOP2 has been suggested to be located at the
base of the chromosome loops. We found that gyrase was
the main enzyme responsible for the generation of loop-size
DNA fragments induced by norﬂoxacin. It is therefore reas-
onable to speculate that DNA gyrase, rather than Topo IV,
is the Topo II that actively participates in the regulation of
loop organization and is located at the base of the nucleoid
DNA loops.
Roles of bacterial supercoiling and structuring factors
in the distribution of Topo IIs on nucleoid DNA:
implications for the organization of bacterial nucleoid
AFM and EM images of nucleoid DNA and other structure-
probing assays indicate the existence of non-random DNA
organization in the bacterial cell (14,32,62). In addition,
earlier reports also suggested the existence of supercoiling-
independent domains on a single nucleoid. As in studies
of mammalian cells incubated with TOP2-targeting drugs
(11,27,28), our study demonstrated that treatment of bacteria
with the Topo II-targeting drug, norﬂoxacin, also induced
loop-size DNA fragmentation of the nucleoid. Thus, the
radial loop model proposed for higher-order chromatin struc-
ture in mammalian chromosomes might also be suitable
for the long-range structure of bacterial nucleoid.
Two type II topoisomerases, gyrase and topoisomerase IV,
have been identiﬁed in E.coli (36,40,63). Puriﬁed gyrase
and Topo IV have different catalytic mechanisms and bio-
chemical activities (43,58,59,64). The major biochemical
activity identiﬁed for gyrase is the introduction of negative
supercoiling, which can efﬁciently relax the positive super-
coiling tension generated from DNA metabolism. Topo IV,
on the other hand, does not have great supercoiling activity
and is mainly involved in the catenation/decatenation reac-
tion. It is therefore generally believed that gyrase contributes
mainly to house-keeping functions involving the regulation
of supercoiling during DNA metabolism processes. Topo
IV, on the other hand, like mammalian TOP2a, plays a
more important role in chromosome segregation. On the
basis of the above properties, one would consider that DNA
gyrase, rather than Topo IV, would be the enzyme located at
the base of DNA loops to regulate the supercoiling tension of
topologically independent loops. Our results showing that
DNA gyrase was the main enzyme responsible for the
norﬂoxacin-induced excision of nucleoid DNA loops support
this notion.
In the present study, we also examined the involvement of
MukB, TopA and TopB in the norﬂoxacin-induced HMW
DNA fragmentation of the E.coli genome. In agreement
with the roles of condensins in eukaryotic higher-order chro-
matin (1), our results showed that MukB protein was a critical
component for the organization of nucleoid DNA loop struc-
ture, as indicated by the lack of generation of loop-sized
Figure 8. DNA loop organization of nucleoid during different growth phases.
LZ36 cells at different growth stages (as indicated by the OD595) were
collected, treated for 30 min at 37 C with 10 mM norfloxacin, and subjected
to PFGE to analyze the nucleoid looped domains.
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MukB function, and that TopA and TopB were not. Previous
mutational studies have ruled out the involvement of the
histone-like proteins, H-NS, HU, FIS and IHF, in the looped
domain organization of the nucleoid in E.coli (65). However,
mutant analysis has also revealed that tight compaction
of nucleoid DNA requires Dps (32). In addition, E.coli
Dps proteins form condensed complexes with DNA (62). It
should be interesting to examine the involvement of Dps
in the norﬂoxacin-induced generation of loop-sized DNA
fragments.
Cis-elements in the loop organization of bacterial
nucleoid: bacterial interspersed mosaic elements
(BIMEs) and bacterial TOP2s
As mentioned above, the gyrase and Topo IV cleavage sites
examined in our study might well represent the relative distri-
butions of Topo IIs on nucleoid. In addition, the average
DNA length of the gyrase-cleaved HMW DNA fragments
( 50 kb) in bacteria was similar to the average size
( 50 kb) of eukaryotic TOP2-excised chromosomal DNA
loops. DNA gyrase might therefore be located on the matrix
to which the bases of the DNA loops are attached. What
might be the cis-DNA elements that interact with gyrase
and mediate the attachment of DNA loops to the matrix? In
eukaryotic cells, M/SARs on chromosomal DNA can interact
with TOP2 and have been proposed to be the cis-elements in
DNA at the base of chromosomal loops. DNA gyrase is also
known to interact with, and cleave, DNA containing BIME
sequences (66–68). The BIME family of bacterial highly
repetitive DNA elements is found in many species of bacteria
(67,69–72). Importantly, the presence of these interspersed
DNA sequences located outside the coding regions suggests
that BIMEs might have a potential role in deﬁning the com-
pact structure of bacterial nucleoid DNA. BIME sequences
contain different repeated motifs and are 40–500 nt in length
(67,69–72). Based on speciﬁc combinations of different
repeated motifs, BIMEs can be further divided into two sub-
families, BIME-1 and BIME-2 (67,69–72). Given our ﬁnding
that Topo IIs contribute to the organization of nucleoid DNA
loop structure, it is tempting to relate the diverse functional
properties of BIMEs to those exhibited by nuclear M/SARs,
in which eukaryotic TOP2s are located.
Interestingly, the afﬁnities of the BIMEs for DNA gyrase,
studied by the gel electrophoretic mobility shift assay
(EMSA), have been shown to be different, with BIME-2
having a higher afﬁnity than BIME-1 (66–68). Furthermore,
our drug-resistant mutant analysis demonstrated that
norﬂoxacin-induced different patterns of HMW DNA frag-
mentation mediated by either gyrase or Topo IV. Further
clariﬁcation of the biochemical interactions between BIMEs
and the TOP2s is required.
Recent advances in cytological and genetic methods have
suggested that different levels of chromatin structures
exist in nucleoid DNA and that several DNA-interacting
proteins are components of these chromatin structures
(1,8,12,14,32,34,35,73). Chromatin structure and DNA super-
coiling are tightly associated with many aspects of cellular
function. DNA topoisomerases are actively involved in both
processes. Consistent with the above mentioned hypothesis,
the patterns of Topo II-mediated cleavage of HMW DNA
fragments in the presence or absence of functional SMC
proteins were different in the mukB mutant. Further studies
identifying the relative contributions of TopA, gyrase and
Topo IV to nucleoid chromatin organization should help
our understanding of nucleoid DNA architecture.
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